DMIMD 2023 - The Introduction of BH4 Therapy in the Irish Paediatric PKU Cohort – Our Three-Year Experience
Recorded lecture from DMIMD 2023: The Introduction of BH4 Therapy in the Irish Paediatric PKU Cohort – Our Three-Year Experience.
Please log in to access this content
Simply log in or register to Nutricia Academy today to access this content as well as a host of other trusted education resources.
In this presentation from the Nutricia’s Dietary Management of Inherited Metabolic Disorders (DMIMD) 2023, Jenny McNulty, Clinical Specialist Dietitian and Maria Irranca, Senior Dietitian discuss their three years experience of introducing Sapropterin Therapy in the Irish paediatric Phenylketonuria (PKU) cohort. The presentation begins with a history of PKU in Ireland before providing an overview of Sapropterin Therapy. Following this, neonatal testing and their protocol for existing patients is discussed. The presentation then concludes with a case study.
Timestamps
00:00 - Introduction
00:40 - History of PKU in Ireland
02:42 - Sapropterin
06:10 - Neonatal Testing
11:12 - Protocol for Existing Patients
14:07 - Response
20:53 - Case Study
You may also be interested in
Also on this website
About Nutricia
Follow us on LinkedIn
Follow us on Twitter
- Nutricia Limited is a company registered in England and Wales with company number 00275552. VAT Number GB436975115
- © 2024 Nutricia. All rights reserved.